A Case Report of Donnai-Barrow Syndrome.

Adv Neonatal Care

Duke University, Chapel Hill, North Carolina (Ms Robinson); and Duke University School of Nursing, Durham, North Carolina (Mss Coe and Bradshaw).

Published: April 2021

Background: A genetic disorder should be considered when an infant presents with multiple congenital anomalies. Because of the acute presentation of an infant with multiple life-threatening defects, a genetic diagnosis of a rare disorder took weeks to delineate.

Clinical Findings: This case describes a late preterm infant who presented at birth with congenital diaphragmatic hernia, tetralogy of Fallot, cleft lip, low-set ears, and hypertelorism.

Primary Diagnosis: Donnai-Barrow syndrome was the final diagnosis confirmed by a defect observed on the LRP2 (2q31.1) gene using sequence analysis. This is a rare disorder that presents with a variety of phenotypic features in infants.

Interventions: Initial neonatal resuscitation in the delivery room included intubation, positive pressure ventilation, and oxygen supplementation. Extracorporeal membrane oxygenation therapy was initiated from day of life 3 to 15. Initial surgery included correction of the congenital diaphragmatic hernia, and further surgical procedures included tracheostomy, gastrostomy tube, circumcision, ventricular septal defect repair, and cleft lip repair. Physical, occupational, and speech therapies were also initiated.

Outcomes: The infant was transported to a pediatric rehabilitation facility at 6 months of life for further management of his chronic lung disease requiring tracheostomy with ventilator dependence.

Practice Recommendations: Early recognition and diagnosis of genetic syndromes can improve family education and guide treatment interventions. An underlying syndrome should be suspected when an infant presents with multiple congenital defects. Infants with Donnai-Barrow syndrome should have thorough cardiac, neurologic, ophthalmologic, audiologic, and renal examinations due to the gene mutation effects on those systems.

Download full-text PDF

Source
http://dx.doi.org/10.1097/ANC.0000000000000766DOI Listing

Publication Analysis

Top Keywords

donnai-barrow syndrome
12
infant presents
8
presents multiple
8
multiple congenital
8
rare disorder
8
congenital diaphragmatic
8
diaphragmatic hernia
8
cleft lip
8
infant
5
case report
4

Similar Publications

Article Synopsis
  • Megalin is a large glycoprotein involved in endocytosis, handling over 60 different compounds, and is primarily found in kidney cells but also in other organs like the brain and lungs.
  • It plays a role in the uptake of both helpful and toxic substances, with a genetic deficiency leading to serious syndromes related to multiple organ issues.
  • The study used cryoelectron microscopy to reveal the structure of megalin and its interactions with ligands and a chaperone protein, providing insights for future research on diseases and potential drug development targeting megalin.
View Article and Find Full Text PDF

The gene encodes megalin (LRP-2/GP330), a large single-spanning transmembrane glycoprotein that serves as a multiligand endocytotic receptor and mediates the reabsorption of albumin in the proximal renal tubule. is implicated in an autosomal recessive disorder characterized by dimorphisms, ocular anomalies, sensorineural deafness, proteinuria, epilepsy, and intellectual disability: a clinical condition called Donnai-Barrow syndrome (DBS) or facio-oculo-acoustico-renal (FOAR) syndrome. Pathogenic variants in have been reported in fewer than 60 patients, but a detailed description of seizures, electroencephalographic patterns, imaging findings, behavioral phenotype, and long-term follow-up is still needed.

View Article and Find Full Text PDF

From pollakiuria to Donnai-Barrow syndrome diagnosis in pediatric age.

Clin Genet

December 2023

Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.

We report the case of two siblings with incomplete Donnai-Barrow syndrome (DBS) phenotype carrying three LRP2 variants never associated before with DBS phenotype.

View Article and Find Full Text PDF

Proteinuria is a prominent feature of chronic kidney disease. Interventions that reduce proteinuria slow the progression of chronic kidney disease and the associated risk of cardiovascular disease. Here, we propose a mechanistic coupling between proteinuria and proprotein convertase subtilisin/kexin type 9 (PCSK9), a regulator of cholesterol and a therapeutic target in cardiovascular disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!